"If your husband or dad is a navy veteran who spent time at a shipyard and he now has mesothelioma or asbestos exposure ...
Nuvalent seeks FDA approval of neladalkib for TKI-pretreated advanced ALK-positive NSCLC, leveraging ALKOVE-1 results demonstrating activity in extracranial disease and brain metastases. ALKOVE-1 ...
Key findings from stage 1 of the PRESERVE-003 Phase 3 clinical trial conducted with participation from Florida Cancer ...
Lung01 Phase 2 trial, with support from IDeate-PanTumor01 Phase 1/2 trialIf approved, ifinatamab deruxtecan would be a first-in-class B7-H3 directed DXd antibody drug conjugate for these patients ...
Clinical trial collaboration and supply agreement between Boehringer and BioNTech to conduct a Phase Ib/II clinical trial to explore complementary immuno-oncology mechanisms in extensive‑stage small ...
The mobile lung screening unit will be coming to Greenwood on May 26. From 9 a.m. to 4 p.m., it will be stationed at Grand ...
Villages along Haryana's Ghaggar river face a cancer crisis linked to polluted water, prompting urgent calls for government ...
Northwestern Medicine scientists have discovered that a specific long non-coding RNA activates oncogenic signaling pathways ...
Boehringer Ingelheim to evaluate combination of DLL3-targeting T-cell engager plus PD-L1/VEGF-A bispecific antibody in small cell lung cancer: Ingelheim, Germany Saturday, April 1 ...
Trastuzumab pamirtecan, a novel antibody-drug conjugate, showed initial efficacy signals in pretreated patients with ...
Lung cancer remains one of the leading causes of cancer-related mortality globally, and immunotherapy has significantly reshaped therapeutic possibilities.
A new study suggests that COVID-19 may slightly increase the risk of lung cancer by triggering a biological chain reaction in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results